HealthEquity’s $257.6 Million Common Stock Offering

Willkie Farr & Gallagher represented HealthEquity, Inc. in the offering.

HealthEquity, Inc., a leading administer of Health Savings Accounts and complementary Consumer-Directed Benefits, executed its offering of 4,600,000 shares of common stock at a price to the public of $56.00 per share.

Gross proceeds to HealthEquity from the offering are expected to be $257,600,000, and the offering is expected to close on July 13, 2020.

Additionally, HealthEquity has granted the underwriters a 30-day option to purchase up to an additional 690,000 shares of its common stock.

Wells Fargo Securities, LLC and J.P. Morgan Securities LLC are acting as lead book-running managers for the offering. Goldman Sachs & Co. LLC, and RBC Capital Markets, LLC are acting as book-running managers for the offering, and BofA Securities, Citizens Capital Markets, Inc., Deutsche Bank Securities and Raymond James & Associates, Inc. are acting as co-managers for the offering.

HealthEquity administers Health Savings Accounts (HSAs) and other consumer-directed benefits for more than 12 million accounts in partnership with employers, benefits advisors, and health and retirement plan providers.

Willkie Farr & Gallagher represented HealthEquity with a tea led by partners Jeffrey Hochman (Picture) and Matthew Haddad and associates Erin Kinney and Andrew Kim.

Involved fees earner: Matthew Haddad – Willkie Farr & Gallagher; Jeffrey Hochman – Willkie Farr & Gallagher; Andrew Kim – Willkie Farr & Gallagher; Erin Kinney – Willkie Farr & Gallagher;

Law Firms: Willkie Farr & Gallagher;

Clients: HealthEquity, Inc.;

Author: Ambrogio Visconti